difference between semaglutide and tirzepatide side effects vs. Semaglutide: What You Should Know GLP-1 drugs such as semaglutide

PCOS-related obesity GLP-1 injectables were administered to women with known PCOS disease for a period of 3 months

Semaglutide is associated with increased neoplasm and tumorigenesis, specifically in the thyroid, bladder, colorectal, and pancreas

In addition, there was upregulation in the expression of the proinflammatory cytokine Tnf and genes involved in the integrated stress response ( Atf3 , Atf5 , Ddit3 and Dele1 ) and reduced expression of the adipokine Adipoq

Several clinical trials are currently investigating whether GLP-1 receptor agonists can slow cognitive decline or reduce Alzheimer's disease risk

In the long term, leg cramps may occur due to changes in overall muscle health

As medicine continues to evolve, embracing technology and comprehensive care models will be key to addressing complex health challenges